Hypergrowth mTORC1 Signals Translationally Activate the ARF Tumor Suppressor Checkpoint

REFERENCES

• Apicelli AJ, et al. 2008. A non-tumor suppressor role for basal p19ARF in maintaining nucleolar structure and function. Mol. Cell. Biol. 28:1068–1080.
   PubMedGoogle Scholar
• Azzam ME, Algranati ID. 1973. Mechanism of puromycin action: fate of ribosomes after release of nascent protein chains from polysomes. Proc. Natl. Acad. Sci. U. S. A. 70:3866–3869.
   PubMed Web of Science ®Google Scholar
• Bates S, et al. 1998. p14ARF links the tumour suppressors RB and p53. Nature 395:124–125.
   PubMed Web of Science ®Google Scholar
• Brady SN, Yu Y, Maggi LBJr, Weber JD. 2004. ARF impedes NPM/B23 shuttling in an Mdm2-sensitive tumor suppressor pathway. Mol. Cell. Biol. 24:9327–9338.
   PubMed Web of Science ®Google Scholar
• Chen J, Kastan MB. 2010. 5′-3′-UTR interactions regulate p53 mRNA translation and provide a target for modulating p53 induction after DNA damage. Genes Dev. 24:2146–2156.
   PubMed Web of Science ®Google Scholar
• Crino PB, Nathanson KL, Henske EP. 2006. The tuberous sclerosis complex. New Engl. J. Med. 355:1345–1356.
   PubMed Web of Science ®Google Scholar
• Dai Y, Grant S. 2010. New insights into checkpoint kinase 1 in the DNA damage response signaling network. Clin. Cancer Res. 16:376–383.
   PubMed Web of Science ®Google Scholar
• de Stanchina E, et al. 1998. E1A signaling to p53 involves the p19(ARF) tumor suppressor. Genes Dev. 12:2434–2442.
   PubMed Web of Science ®Google Scholar
• Elledge SJ. 1996. Cell cycle checkpoints: preventing an identity crisis. Science 274:1664–1672.
   PubMed Web of Science ®Google Scholar
• Grech G, et al. 2008. Igbp1 is part of a positive feedback loop in stem cell factor-dependent, selective mRNA translation initiation inhibiting erythroid differentiation. Blood 112:2750–2760.
   PubMed Web of Science ®Google Scholar
• Guertin DA, Sabatini DM. 2007. Defining the role of mTOR in cancer. Cancer Cell 12:9–22.
   PubMed Web of Science ®Google Scholar
• Hanahan D, Weinberg RA. 2011. Hallmarks of cancer: the next generation. Cell 144:646–674.
   PubMed Web of Science ®Google Scholar
• Hay N, Sonenberg N. 2004. Upstream and downstream of mTOR. Genes Dev. 18:1926–1945.
   PubMed Web of Science ®Google Scholar
• Inoki K, Corradetti MN, Guan KL. 2005. Dysregulation of the TSC-mTOR pathway in human disease. Nat. Genet. 37:19–24.
   PubMed Web of Science ®Google Scholar
• Inoki K, Guan KL. 2009. Tuberous sclerosis complex, implication from a rare genetic disease to common cancer treatment. Hum. Mol. Genet. 18:R94–100.
   PubMedGoogle Scholar
• Inoue K, Mallakin A, Frazier DP. 2007. Dmp1 and tumor suppression. Oncogene 26:4329–4335.
   PubMed Web of Science ®Google Scholar
• Inoue K, Roussel MF, Sherr CJ. 1999. Induction of ARF tumor suppressor gene expression and cell cycle arrest by transcription factor DMP1. Proc. Natl. Acad. Sci. U. S. A. 96:3993–3998.
   PubMed Web of Science ®Google Scholar
• Inoue K, et al. 2000. Disruption of the ARF transcriptional activator DMP1 facilitates cell immortalization, Ras transformation, and tumorigenesis. Genes Dev. 14:1797–1809.
   PubMed Web of Science ®Google Scholar
• Inoue K, Zindy F, Randle DH, Rehg JE, Sherr CJ. 2001. Dmp1 is haplo-insufficient for tumor suppression and modifies the frequencies of Arf and p53 mutations in Myc-induced lymphomas. Genes Dev. 15:2934–2939.
   PubMed Web of Science ®Google Scholar
• Kamijo T, Bodner S, van de Kamp E, Randle DH, Sherr CJ. 1999. Tumor spectrum in ARF-deficient mice. Cancer Res. 59:2217–2222.
   PubMed Web of Science ®Google Scholar
• Kamijo T, et al. 1997. Tumor suppression at the mouse INK4a locus mediated by the alternative reading frame product p19ARF. Cell 91:649–659.
   PubMed Web of Science ®Google Scholar
• Kastan MB, Bartek J. 2004. Cell-cycle checkpoints and cancer. Nature 432:316–323.
   PubMed Web of Science ®Google Scholar
• Kladney RD, et al. 2010. Tuberous sclerosis complex 1: an epithelial tumor suppressor essential to prevent spontaneous prostate cancer in aged mice. Cancer Res. 70:8937–8947.
   PubMedGoogle Scholar
• Knaup KX, et al. 2009. Mutual regulation of hypoxia-inducible factor and mammalian target of rapamycin as a function of oxygen availability. Mol. Cancer Res. 7:88–98.
   PubMed Web of Science ®Google Scholar
• Kuo ML, den Besten W, Bertwistle D, Roussel MF, Sherr CJ. 2004. N-terminal polyubiquitination and degradation of the Arf tumor suppressor. Genes Dev. 18:1862–1874.
   PubMed Web of Science ®Google Scholar
• Kwiatkowski DJ, et al. 2002. A mouse model of TSC1 reveals sex-dependent lethality from liver hemangiomas, and up-regulation of p70S6 kinase activity in Tsc1 null cells. Hum. Mol. Genet. 11:525–534.
   PubMed Web of Science ®Google Scholar
• Lee CH, et al. 2007. Constitutive mTOR activation in TSC mutants sensitizes cells to energy starvation and genomic damage via p53. EMBO J. 26:4812–4823.
   PubMed Web of Science ®Google Scholar
• Livak KJ, Schmittgen TD. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2−ΔΔCT method. Methods 25:402–408.
   PubMed Web of Science ®Google Scholar
• Ma XM, Blenis J. 2009. Molecular mechanisms of mTOR-mediated translational control. Nat. Rev. Mol. Cell Biol. 10:307–318.
   PubMed Web of Science ®Google Scholar
• Reference deleted.
   Google Scholar
• Reference deleted.
   Google Scholar
• Mills JR, et al. 2008. mTORC1 promotes survival through translational control of Mcl-1. Proc. Natl. Acad. Sci. U. S. A. 105:10853–10858.
   PubMed Web of Science ®Google Scholar
• Olanich ME, Moss BL, Piwnica-Worms D, Townsend RR, Weber JD. 2011. Identification of FUSE-binding protein 1 as a regulatory mRNA-binding protein that represses nucleophosmin translation. Oncogene 30:77–86.
   PubMedGoogle Scholar
• Palmero I, Pantoja C, Serrano M. 1998. p19ARF links the tumour suppressor p53 to Ras. Nature 395:125–126.
   PubMed Web of Science ®Google Scholar
• Pelletier CL, et al. 2007. TSC1 sets the rate of ribosome export and protein synthesis through nucleophosmin translation. Cancer Res. 67:1609–1617.
   PubMedGoogle Scholar
• Proud CG. 2007. Signalling to translation: how signal transduction pathways control the protein synthetic machinery. Biochem. J. 403:217–234.
   PubMed Web of Science ®Google Scholar
• Quelle DE, Zindy F, Ashmun RA, Sherr CJ. 1995. Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest. Cell 83:993–1000.
   PubMed Web of Science ®Google Scholar
• Radfar A, Unnikrishnan I, Lee HW, DePinho RA, Rosenberg N. 1998. p19(Arf) induces p53-dependent apoptosis during abelson virus-mediated pre-B cell transformation. Proc. Natl. Acad. Sci. U. S. A. 95:13194–13199.
   PubMed Web of Science ®Google Scholar
• Roussel MF, Theodoras AM, Pagano M, Sherr CJ. 1995. Rescue of defective mitogenic signaling by D-type cyclins. Proc. Natl. Acad. Sci. U. S. A. 92:6837–6841.
   PubMed Web of Science ®Google Scholar
• Saporita AJ, Maggi LBJr, Apicelli AJ, Weber JD. 2007. Therapeutic targets in the ARF tumor suppressor pathway. Curr. Med. Chem. 14:1815–1827.
   PubMed Web of Science ®Google Scholar
• Shaw RJ, Cantley LC. 2006. Ras, PI(3)K and mTOR signalling controls tumour cell growth. Nature 441:424–430.
   PubMed Web of Science ®Google Scholar
• Sherr CJ. 2006. Divorcing ARF and p53: an unsettled case. Nat. Rev. Cancer 6:663–673.
   PubMed Web of Science ®Google Scholar
• Spriggs KA, Bushell M, Willis AE. 2010. Translational regulation of gene expression during conditions of cell stress. Mol. Cell 40:228–237.
   PubMed Web of Science ®Google Scholar
• Sreeramaneni R, Chaudhry A, McMahon M, Sherr CJ, Inoue K. 2005. Ras-Raf-Arf signaling critically depends on the Dmp1 transcription factor. Mol. Cell. Biol. 25:220–232.
   PubMed Web of Science ®Google Scholar
• Stefani G, Fraser CE, Darnell JC, Darnell RB. 2004. Fragile X mental retardation protein is associated with translating polyribosomes in neuronal cells. J. Neurosci. 24:7272–7276.
   PubMed Web of Science ®Google Scholar
• Strezoska Z, Pestov DG, Lau LF. 2000. Bop1 is a mouse WD40 repeat nucleolar protein involved in 28S and 5.8S RRNA processing and 60S ribosome biogenesis. Mol. Cell. Biol. 20:5516–5528.
   PubMed Web of Science ®Google Scholar
• Takagi M, Absalon MJ, McLure KG, Kastan MB. 2005. Regulation of p53 translation and induction after DNA damage by ribosomal protein L26 and nucleolin. Cell 123:49–63.
   PubMed Web of Science ®Google Scholar
• Tee AR, et al. 2002. Tuberous sclerosis complex-1 and -2 gene products function together to inhibit mammalian target of rapamycin (mTOR)-mediated downstream signaling. Proc. Natl. Acad. Sci. U. S. A. 99:13571–13576.
   PubMed Web of Science ®Google Scholar
• Thermann R, Hentze MW. 2007. Drosophila miR2 induces pseudo-polysomes and inhibits translation initiation. Nature 447:875–878.
   PubMed Web of Science ®Google Scholar
• Volanakis EJ, Sherr CJ. 2010. Developmental strategies for evasion of Arf tumor suppression. Cell Cycle 9:14–15.
   PubMed Web of Science ®Google Scholar
• Watnick RS, Cheng YN, Rangarajan A, Ince TA, Weinberg RA. 2003. Ras modulates Myc activity to repress thrombospondin-1 expression and increase tumor angiogenesis. Cancer Cell 3:219–231.
   PubMedGoogle Scholar
• Weber JD, et al. 2000. Cooperative signals governing ARF-mdm2 interaction and nucleolar localization of the complex. Mol. Cell. Biol. 20:2517–2528.
   PubMed Web of Science ®Google Scholar
• Weber JD, Taylor LJ, Roussel MF, Sherr CJ, Bar-Sagi D. 1999. Nucleolar Arf sequesters Mdm2 and activates p53. Nat. Cell Biol. 1:20–26.
   PubMed Web of Science ®Google Scholar
• Weber RG, et al. 2007. Frequent loss of chromosome 9, homozygous CDKN2A/p14(ARF)/CDKN2B deletion and low TSC1 mRNA expression in pleomorphic xanthoastrocytomas. Oncogene 26:1088–1097.
   PubMed Web of Science ®Google Scholar
• Zhang H, et al. 2003. Loss of Tsc1/Tsc2 activates mTOR and disrupts PI3K-Akt signaling through downregulation of PDGFR. J. Clin. Invest. 112:1223–1233.
   PubMed Web of Science ®Google Scholar
• Zindy F, et al. 1998. Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization. Genes Dev. 12:2424–2433.
   PubMed Web of Science ®Google Scholar
• Zoncu R, Efeyan A, Sabatini DM. 2011. mTOR: from growth signal integration to cancer, diabetes and ageing. Nat. Rev. Mol. Cell Biol. 12:21–35.
   PubMed Web of Science ®Google Scholar